SScience Read More Semaglutide changes gut bacteria in rats beyond what eating less explainsOctober 27, 2026 A controlled feeding experiment in male and female rats investigates whether changes in gut bacteria follow reduced eating…
HHealth Read More Stopping GLP-1 drugs often brings weight back. A small trial suggests ways to slow itOctober 12, 2026 Maintaining weight loss after medication ends is a difficult transition, prompting researchers to test two practical support options…
HHealth Read More Digital companion apps help secure long-term habits during GLP-1 therapySeptember 9, 2026 Glucagon-like peptide-1 (GLP-1) medications have revolutionized weight management, yet high dropout rates and rapid weight regain remain significant…
MMedication Read More GLP-1 drugs appear psychiatrically safe, but one finding still raises questionsSeptember 7, 2026 With millions of patients now taking GLP-1 drugs, researchers examined whether concerns about depression and suicidality are supported…
SScience Read More Ten-million-person study links semaglutide to lower COVID-19 mortalityJuly 31, 2026 After accounting for major health differences between semaglutide users and non-users, researchers identified a striking mortality association that…
HHealth Read More Semaglutide and tirzepatide linked to fewer alcohol-related hospital visitsJuly 24, 2026 A large US health-record study suggests newer GLP-1 drugs may reduce alcohol-related acute-care visits, but the findings remain…
HHealth Read More Popular diabetes drugs do not alter the risk of developing a blinding eye conditionJuly 17, 2026 An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs) – a type of…
HHealth Read More Physical activity declines after starting GLP-1 obesity treatmentsJune 14, 2026 Adults with obesity losing weight with glucagon-like peptide-1 (GLP-1) receptor agonist medications significantly decreased their physical activity, which…
HHealth Read More Weight loss drugs like Ozempic also improve liver health | HealthApril 15, 2026 (Photo by Haberdoedas Photography via Pexels) By Talker By Stephen Beech Popular weight loss drugs such as Ozempic…
HHealth Read More Metformin’s blood sugar control starts in the brain, not just the liver, study findsAugust 4, 2025 Scientists uncover how low-dose metformin targets brain pathways to lower blood sugar, opening fresh avenues for safer and…
HHealth Read More Which GLP-1 meds have the most side effects? Study of 60,000 Facebook posts gives answersJuly 28, 2025 A deep dive into public Facebook posts uncovers the real-world side effect patterns of GLP-1 medications, revealing what…